Article info
Inflammatory bowel disease
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
- Professor M A Kamm, St Vincent’s Hospital, University Department of Medicine, Victoria Parade, Fitzroy 3065, Melbourne, Australia; Kamm{at}ic.ac.uk
Citation
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
Publication history
- Revised January 28, 2008
- Accepted January 28, 2008
- First published February 13, 2008.
Online issue publication
October 26, 2017
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group & British Society of Gastroenterology